Abstract:Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and the fourth leading cause of cancer mortality worldwide. It is often diagnosed at an advanced stage, and hence typically has a poor prognosis. A number of distinct molecules have been recently identified as playing a role in the control of cancer progression. However, patients with HCC have a highly variable clinical course, indicating that HCC comprises several biologically distinctive subgroups reflecting a molecular heterogeneity of the tumors. To evaluate potential biomarkers in HCC, we employed multiple methods in this study, including qPCR, immunostaining methods and tissue microarrays (TMAs), as well as histological and pathological analysis, to assess TGFβ, XPO4, elF5A2 and ANGPTL4 in cancerous and paracancerous liver tissues from 280 patients suffering from liver cancer. Our results found that all four indicators were located in the cytoplasm and distributed in cancerous and paracancerous liver tissues. Generally, there were higher levels of these indicators in paracancerous, compared with cancerous, liver tissues. These four indicators were correlated and modulated among each other. In connection with patient clinical and revisit information, statistical analysis determined that TGFβ1 in paracancerous liver tissue was positively correlated with tumor size. Higher production of TGFβ1 in paracancerous liver tissue was always associated with bigger liver tumors. XPO4 in cancerous liver tissue and TGFβ1 in paracancerous liver tissue were positively correlated with tumor differentiation. TGFβ1, ANGPTL4 and elF5A2 were also positively correlated with the T classification of tumors. Additionally, higher levels of XPO4 in cancerous liver tissue suggested that the patient would have a better prognosis and survival rate. However, higher production of XPO4 in paracancerous liver tissue suggested a worse prognosis. All the results above provide new insights into better understanding biological indicators, such as XPO4, TGFβ1, ANGPTL4 and elF5A2, in the prediction and evaluation of liver cancer, as well as signaling pathways in the control of liver cancer. XPO4 and TGFβ1 may serve as useful markers to evaluate the size and prognosis of liver cancer.

Hypoxia-inducible Factor 1 Alpha-Activated Angiopoietin-Like Protein 4 Contributes to Tumor Metastasis Via Vascular Cell Adhesion Molecule-1/Integrin Β1 Signaling in Human Hepatocellular Carcinoma.

Anti-tumor Effect of Recombinant Retroviral Vector-Mediated Human ANGPTL4 Gene Transfection.

Effect of Deletion of ANGPTL4 Gene on Viability, Migration and Invasion Ability and Apoptosis of Hepatocellular Carcinoma Cells

Author Correction: Integrin Β4 Promotes Cell Invasion and Epithelial-Mesenchymal Transition Through the Modulation of Slug Expression in Hepatocellular Carcinoma

ANGPTL1 Interacts with Integrin Α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.

Angiopoietin-Related Protein 4-Transcript 3 Increases the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma Cells and Inhibits Apoptosis

Angiopoietin-like 4 (angptl4) and cancer

Angiopoietin-like 4 Enhances Metastasis and Inhibits Apoptosis Via Inducing Bone Morphogenetic Protein 7 in Colorectal Cancer Cells.

Up-regulated ITGB4 Promotes Hepatocellular Carcinoma Metastasis by Activating Hypoxia-Mediated Glycolysis and Cancer-Associated Fibroblasts

An Integrin Beta4-Egfr Unit Promotes Hepatocellular Carcinoma Lung Metastases by Enhancing Anchorage Independence Through Activation of FAK-AKT Pathway.

Emerging Roles of Angiopoietin-like 4 in Human Cancer

Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives

ETV4 Facilitates Angiogenesis in Hepatocellular Carcinoma by Upregulating MMP14 Expression

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

ANGPTL4 Overexpression Inhibits Tumor Cell Adhesion and Migration and Predicts Favorable Prognosis of Triple-Negative Breast Cancer

FGF19/FGFR4-mediated Elevation of ETV4 Facilitates Hepatocellular Carcinoma Metastasis by Upregulating PD-L1 and CCL2

ANGPTL4 Stabilizes Bone Morphogenetic Protein 7 Through Deubiquitination and Promotes HCC Proliferation via the SMAD/MAPK Pathway

Evaluation of TGFβ, XPO4, Elf5a2 and ANGPTL4 As Biomarkers in HCC

ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1

Expression of angiopoietins, Tie2 and vascular endothelial growth factor in anglogenesis and progression of hepatocellular carcinoma

HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression